In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Labcorp's current price trades below a high-confidence fair value of $358.16, indicating a 14.1% implied upside, supported by DCF and P/E valuations, though EV/EBITDA suggests even higher valuation. Financial health scores are moderate (2.80/5), with efficiency notably weaker. Monte Carlo analysis reveals substantial volatility (130.06% CV) and significant downside risk (44.4%), highlighting considerable valuation uncertainty despite upside potential.